Expression of the Grb2-related RET adapter protein Grap-2 in human medullary thyroid carcinoma

Cancer Letters

Volumn 275, Issue 2, 2009, Pages 194-197

  Ludwig, Leopold ^a   Oswald, Franz ^b   Hoang Vu, Cuong ^c   Dralle, Henning ^c   Hildt, Eberhard ^d   Schmid, Roland M ^a   Karges, Wolfram ^e  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^d UNIVERSITY OF FREIBURG   (Germany)

^e RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Cancer; Expression; Oncogene; Thyroid; Tyrosine kinase

Indexed keywords

GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; PROTEIN GRAP2; PROTEIN RET; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; MITOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; THYROID MEDULLARY CARCINOMA;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BASE SEQUENCE; CARCINOMA, MEDULLARY; DNA PRIMERS; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; THYROID NEOPLASMS;

EID: 59349105673     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.10.010     Document Type: Article

References (20)

1. Takahashi M., Ritz J., and Cooper G.M. Activation of a novel human transforming gene ret by DNA rearrangement. Cell 42 (1985) 581-588
2. Santoro M., Carlomagno F., Melillo R.M., and Fusco A. Dysfunction of the RET receptor in human cancer. Cell. Mol. Life Sci. 61 (2004) 2954-2964
3. Hofstra R.M., Landsvater R.M., Ceccherini I., Stulp R.P., Stelwagen T., et al. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 367 (1994) 375-376
4. Mulligan L.M., Kwok J.B., Healey C.S., Elsdon M.J., Eng C., et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363 (1993) 458-460
5. Grieco M., Santoro M., Berlingieri M.T., Melillo R.M., Donghi R., et al. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell 60 (1990) 557-563
6. Arighi E., Borrello M.G., and Sariola H. RET tyrosine kinase signaling in development and cancer. Cytokine Growth Factor Rev. 16 (2005) 441-467
7. de Groot J.W., Links T.P., Plukker J.T., Lips C.J., and Hofstra R.M. RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors. Endocr. Rev. 27 (2006) 535-560
8. Ludwig L., Kessler H., Wagner M., Hoang-Vu C., Dralle H., et al. Nuclear factor-kappaB is constitutively active in C-cell carcinoma and required for RET-induced transformation. Cancer Res. 61 (2001) 4526-4535
9. Ludwig L., Kessler H., Hoang-Vu C., Dralle H., Adler G., et al. Grap-2, a novel RET binding protein, is involved in RET mitogenic signaling. Oncogene 22 (2003) 5362-5366
10. Qiu M., Hua S., Agrawal M., Li G., Cai J., et al. Molecular cloning and expression of human grap-2, a novel leukocyte-specific SH2- and SH3-containing adaptor-like protein that binds to gab-1. Biochem. Biophys. Res. Commun. 253 (1998) 443-447
11. Liu S.K., Berry D.M., and McGlade C.J. The role of Gads in hematopoietic cell signalling. Oncogene 20 (2001) 6284-6290
12. Yoder J., Pham C., Iizuka Y.M., Kanagawa O., Liu S.K., et al. Requirement for the SLP-76 adaptor GADS in T cell development. Science 291 (2001) 1987-1991
13. Watanabe R., Harada Y., Takeda K., Takahashi J., Ohnuki K., et al. Grb2 and Gads exhibit different interactions with CD28 and play distinct roles in CD28-mediated costimulation. J. Immunol. 177 (2006) 1085-1091
14. Kim J.E., and White F.M. Quantitative analysis of phosphotyrosine signaling networks triggered by CD3 and CD28 costimulation in Jurkat cells. J. Immunol. 176 (2006) 2833-2843
15. Machens A., Niccoli-Sire P., Hoegel J., Frank-Raue K., van Vroonhoven T.J., et al. Early malignant progression of hereditary medullary thyroid cancer. N. Engl. J. Med. 349 (2003) 1517-1525
16. Hayashi H., Ichihara M., Iwashita T., Murakami H., Shimono Y., et al. Characterization of intracellular signals via tyrosine 1062 in RET activated by glial cell line-derived neurotrophic factor. Oncogene 19 (2000) 4469-4475
17. Karin M., and Greten F.R. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 5 (2005) 749-759
18. Perkins N.D. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat. Rev. Mol. Cell Biol. 8 (2007) 49-62
19. Basseres D.S., and Baldwin A.S. Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene 25 (2006) 6817-6830
20. Besset V., Scott R.P., and Ibanez C.F. Signaling complexes and protein-protein interactions involved in the activation of the Ras and phosphatidylinositol 3-kinase pathways by the c-Ret receptor tyrosine kinase. J. Biol. Chem. 275 (2000) 39159-39166